Award recordCONTRACT

GUARDIAN PHARMACY OF INDIANAPOLIS NUCLEAR, LLC

PIID VA25112J0012· VHA· 583-INDIANAPOLIS· 6505 · DRUGS AND BIOLOGICALS· FY2012· $656,055 net obligations· UEI DR3USD14LYJ4· IN

Description

DECREASE FUNDS FOR RADIOPHARMACEUTICALS TO CLOSE OUT OPTION YEAR, FY13

Base award description: RADIOPHARMACEUTICALS FOR RLRVAMC

First action · last action
2011-10-01 · 2013-12-30
Transactions
6
First transaction's obligation
$492,748
Base + all options value (sum of deltas)
$656,055
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
2
SDVOSB flag on record
No
Parent IDV
VA251P1142
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 6 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$869,806$0Base award · 2011-10-01 · this action $492,748 · running total $492,748Modification P00002 · 2012-09-12 · this action -$139,020 · running total $353,728Modification P00001 · 2012-10-01 · this action $516,078 · running total $869,806Modification P00003 · 2012-12-10 · this action -$21,182 · running total $848,624Modification P00004 · 2013-08-27 · this action -$180,000 · running total $668,624Modification P00005 · 2013-12-30 · this action -$12,569 · running total $656,055
  • Base2011-10-01+$492,748= $492,748
  • Mod P000022012-09-12-$139,020= $353,728
  • Mod P000012012-10-01+$516,078= $869,806
  • Mod P000032012-12-10-$21,182= $848,624
  • Mod P000042013-08-27-$180,000= $668,624
  • Mod P000052013-12-30-$12,569= $656,055
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2011-10-01+$492,748$492,748RADIOPHARMACEUTICALS FOR RLRVAMC
Mod P00002· FUNDING ONLY ACTION2012-09-12−$139,020$353,728REDUCTION IN ESTIMATED QUANTITIES - RADIOPHARMACEUTICALS FOR RLRVAMC
Mod P00001· EXERCISE AN OPTION2012-10-01+$516,078$869,806RADIOPHARMACEUTICALS FOR RLRVAMC OPT YR 1
Mod P00003· FUNDING ONLY ACTION2012-12-10−$21,182$848,624DECREASE FUNDS FOR RADIOPHARMACEUTICALS BASE YEAR, FY12
Mod P00004· FUNDING ONLY ACTION2013-08-27−$180,000$668,624DECREASE FUNDS FOR RADIOPHARMACEUTICALS OPTION YEAR, FY13
Mod P00005· CLOSE OUT2013-12-30−$12,569$656,055DECREASE FUNDS FOR RADIOPHARMACEUTICALS TO CLOSE OUT OPTION YEAR, FY13

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI DR3USD14LYJ4)

AwardOffice · PSC / listingNet obligationsFY
36C25026N0072250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$350,000FY2026
36C25025N0041250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$350,003FY2025
36C25024N0057250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$305,179FY2024
36C25023D0083250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$0FY2023
36C25019P0752250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$11,904FY2019
36C25019P0558250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$36,393FY2019

Other recipients under 6505 from 583-INDIANAPOLIS (most recent first)

AwardRecipientOfficeNet obligationsFY
VA25116F0847ACTELION PHARMACEUTICALS US, INC.583-INDIANAPOLIS$4,614FY2016
VA25116F0730CSL BEHRING L.L.C.583-INDIANAPOLIS$26,724FY2016
VA25116F0509CSL BEHRING L.L.C.583-INDIANAPOLIS$26,724FY2016
VA25116F0406ROCHE DIAGNOSTICS CORPORATION583-INDIANAPOLIS$17,601FY2016
VA25116P0414ASD SPECIALTY HEALTHCARE, LLC583-INDIANAPOLIS$35,317FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25112J0012_3600_VA251P1142_3600 · retrieved 2026-09-26.